Vyriad launches IMMUNO-COV™, the first scalable neutralizing antibody test for COVID-19 Read More

Vyriad is interested in hearing from you.  Please see the media and investor contacts or use our Contact Us form to e-mail your information request.

Contact Us

Vyriad Headquarters

2900 37th Street NW

Building 110

Rochester, MN 55901

507-289-0944

info@vyriad.com

Investor Relations

Barb Duckett

507-289-0944

bduckett@vyriad.com

Media Relations

David Walsh

651-503-8248

dwalsh@vyriad.com